Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER TSUNG LUNG HO

Allopathic & Osteopathic Physicians Dermatology

NPI
1679507537
CMS profile
303166
Location
LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$101,983.69

134 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $71,694.47 82
ABBVIE INC. $15,933.14 32
Arcutis Biotherapeutics, Inc. $10,210.38 12
PFIZER INC. $2,100.00 2
Lilly USA, LLC $1,773.62 2
Dermavant Sciences, Inc. $192.80 1
GENZYME CORPORATION $30.74 1
UCB, Inc. $24.33 1
Incyte Corporation $24.21 1

Page 1 of 3; records 1–50 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER TSUNG LUNG HO

NPI 1679507537 · CMS profile ID 303166

Allopathic & Osteopathic Physicians / Dermatology

LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 3; records 1–50 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1679507537?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER TSUNG LUNG HO, NPI 1679507537, CMS profile ID 303166. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 3; records 1–50 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1679507537?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). CHRISTOPHER TSUNG LUNG HO, NPI 1679507537, CMS profile ID 303166. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 3; records 1–50 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1679507537?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
CHRISTOPHER TSUNG LUNG HO, NPI 1679507537, CMS profile ID 303166, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 3; records 1–50 of 134 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1679507537?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

134 matching records · $101,983.69 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 134 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 134.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $1,350.0012/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484911 CMS
ABBVIE INC. $1,350.0012/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484913 CMS
ABBVIE INC. $12.5010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484909 CMS
Arcutis Biotherapeutics, Inc. $2,250.0010/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044674249 CMS
Arcutis Biotherapeutics, Inc. $27.0310/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044674261 CMS
Amgen Inc. $49.8910/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555451 CMS
Amgen Inc. $5.0010/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555453 CMS
Amgen Inc. $261.9810/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555455 CMS
Amgen Inc. $27.5110/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555457 CMS
Amgen Inc. $3,000.0010/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555461 CMS
Amgen Inc. $2,000.0010/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555463 CMS
Amgen Inc. $46.9110/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555465 CMS
Amgen Inc. $46.0510/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555467 CMS
Amgen Inc. $3,000.0010/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555475 CMS
Amgen Inc. $25.9410/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555477 CMS
Amgen Inc. $3,000.0009/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555459 CMS
ABBVIE INC. $33.1009/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484907 CMS
Amgen Inc. $29.1709/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555469 CMS
Amgen Inc. $183.0809/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555439 CMS
Amgen Inc. $195.7909/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555441 CMS
Amgen Inc. $33.2009/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555443 CMS
Amgen Inc. $144.5009/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555445 CMS
Amgen Inc. $24.4209/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555447 CMS
Arcutis Biotherapeutics, Inc. $2,250.0009/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044674299 CMS
Arcutis Biotherapeutics, Inc. $11.9609/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044674313 CMS
ABBVIE INC. $2,250.0009/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484905 CMS
ABBVIE INC. $7.3509/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484903 CMS
Dermavant Sciences, Inc. $192.8009/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991201125 CMS
ABBVIE INC. $0.7309/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484895 CMS
ABBVIE INC. $6.7809/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484897 CMS
ABBVIE INC. $2.9009/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484899 CMS
ABBVIE INC. $3.3309/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484901 CMS
Arcutis Biotherapeutics, Inc. $123.0409/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044674325 CMS
ABBVIE INC. $122.4709/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484893 CMS
ABBVIE INC. $1,350.0009/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997484891 CMS
Incyte Corporation $24.2108/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044935609 CMS
Amgen Inc. $2,500.0008/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555435 CMS
Amgen Inc. $195.7908/10/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555449 CMS
Amgen Inc. $3.9305/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555397 CMS
Amgen Inc. $3.5005/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555403 CMS
Amgen Inc. $3,000.0005/30/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555405 CMS
Amgen Inc. $2,500.0005/30/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555407 CMS
Amgen Inc. $3,000.0005/30/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555427 CMS
Amgen Inc. $27.3405/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555415 CMS
Amgen Inc. $3.9305/24/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555423 CMS
Amgen Inc. $3.5005/24/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555425 CMS
Amgen Inc. $3,000.0005/24/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555433 CMS
Amgen Inc. $2,000.0005/24/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555437 CMS
Amgen Inc. $1,000.0005/24/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555473 CMS
Amgen Inc. $32.2405/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020555419 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $205,908.65 343
PY2020 $77,774.96 206
PY2021 $133,527.00 260
PY2022 $134,738.68 292
PY2023 $101,983.69 134
PY2024 $54,522.15 69
PY2025 $22,056.16 20

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $105,671.24 11
PY2021 Principal investigator $144,092.68 4
PY2020 Principal investigator $655,216.54 25
PY2019 Principal investigator $403,059.40 25

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $32,787.00 12/20/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933733
Principal investigator 1 Bausch Health US, LLC $13,932.00 12/19/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER INC
MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2-ARM, PARALLEL GROUP EFFICACYSAFETY STUDY No dispute reported 06/30/2026 684366797
Principal investigator 1 Dr.Reddy's Laboratories,Inc. $3,577.20 12/12/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER INC
Randomized,Doube-Blind, Placebo-Controlled, Multicenter, 24 week study to assess the Efficacy and Safety of PPC-06, extended release tablets in Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 701425683
Principal investigator 1 LEO Pharma AS $500.00 11/21/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER
TRALOKINUMAB VACCINE RESPONSE TIME No dispute reported 06/30/2026 686861221
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $7,078.00 11/20/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933717
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $27,981.00 11/20/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933725
Principal investigator 1 Bausch Health US, LLC $7,000.00 11/07/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER INC
MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2-ARM, PARALLEL GROUP EFFICACYSAFETY STUDY No dispute reported 06/30/2026 684365917
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $1,404.00 10/20/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933703
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $17,523.00 10/20/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933711
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $14,661.00 09/20/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933695
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $3,000.00 09/13/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933689
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $17,100.00 08/20/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933685
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $17,370.00 07/20/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933675
Principal investigator 1 LEO Pharma AS $2,640.00 07/16/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER
TRALOKINUMAB VACCINE RESPONSE TIME No dispute reported 06/30/2026 686856613
Principal investigator 1 Dr.Reddy's Laboratories,Inc. $831.60 07/02/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER INC
Randomized,Doube-Blind, Placebo-Controlled, Multicenter, 24 week study to assess the Efficacy and Safety of PPC-06, extended release tablets in Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 701425673
Principal investigator 1 Dr.Reddy's Laboratories,Inc. $2,493.00 07/01/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER INC
Randomized,Doube-Blind, Placebo-Controlled, Multicenter, 24 week study to assess the Efficacy and Safety of PPC-06, extended release tablets in Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 701425625
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $183,299.40 06/26/2019 Non-covered Recipient Entity
La Universal Research Center
A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study with an Induction Period Followed by a Randomized Maintenance Period to Evaluate the Clinical Efficacy and Safety of BMS-986165 in Subjects with Moderate to Severe Psoriasis No dispute reported 06/30/2026 639762983
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $12,636.00 06/20/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933668
Principal investigator 1 TARO PHARMACEUTICALS USA, INC. $531.00 05/20/2019 Non-covered Recipient Entity
L.A. Universal Research Center, Inc.
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris No dispute reported 06/30/2026 703933661
Principal investigator 1 Dr.Reddy's Laboratories,Inc. $1,656.00 05/07/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER INC
Randomized,Doube-Blind, Placebo-Controlled, Multicenter, 24 week study to assess the Efficacy and Safety of PPC-06, extended release tablets in Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 701425509
Principal investigator 1 Dr.Reddy's Laboratories,Inc. $2,686.50 04/10/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER INC
Randomized,Doube-Blind, Placebo-Controlled, Multicenter, 24 week study to assess the Efficacy and Safety of PPC-06, extended release tablets in Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 701425495
Principal investigator 1 Dr.Reddy's Laboratories,Inc. $24,527.70 04/08/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER INC
Randomized,Doube-Blind, Placebo-Controlled, Multicenter, 24 week study to assess the Efficacy and Safety of PPC-06, extended release tablets in Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 701425473
Principal investigator 1 LEO Pharma AS $4,775.00 02/26/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER
TRALOKINUMAB VACCINE RESPONSE TIME No dispute reported 06/30/2026 686852447
Principal investigator 1 PFIZER INC. $70.00 01/31/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH
JAK1 DUPILUMAB COMPARATOR STUDY No dispute reported 06/30/2026 671643133
Principal investigator 1 Dr.Reddy's Laboratories,Inc. $3,000.00 01/02/2019 Non-covered Recipient Entity
LA UNIVERSAL RESEARCH CENTER INC
Randomized,Doube-Blind, Placebo-Controlled, Multicenter, 24 week study to assess the Efficacy and Safety of PPC-06, extended release tablets in Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 701425693